PhaseBio Pharmaceuticals Inc: 8-K filed Nov 29, 2023

Form type

8-K

Filing date

Nov 29, 2023

Accession number

0001169245-23-000056

Filer

PhaseBio Pharmaceuticals Inc (CIK 1169245)